Developer docs
API playgroundTry for free, no card

Search company profiles

ALS ONE

Full company profile

uuid00revzr

Namestring
ALS ONE
Legal namestring
ALS ONE
Websiteurl
alsone.org
Company typeenum
Private
Founded yearint
2015
Descriptiontext

ALS ONE is a Massachusetts-based nonprofit organization founded around 2015 that unites world-leading ALS researchers, clinicians, care providers, corporate leaders, and families affected by ALS to accelerate treatment discovery and deliver practical care resources. It operates through three integrated pillars: Research (a collaborative partnership drawing on ALS Therapy Development Institute, UMass Medical School, Massachusetts General Hospital / Healey Center for ALS, and Compassionate Care ALS), Care (provision of equipment, resources, and support services to families living with ALS), and Fundraising (donation campaigns that underwrite both research and care programs).

Its core technology stack is non-software: the principal proprietary contribution disclosed is PERLA®, a new class of organ preservation solution (PPS) co-developed with Barcelona-based IDIBAPS that has received CE marking for clinical use in organ transplantation, signaling activity beyond pure ALS into adjacent translational research. The organization is community-led, headcount is 1–10, and revenue is sourced from donations and fundraising rather than commercial product sales; services to families are provided at no cost.

On February 11, 2026, ALS ONE announced a strategic integration with the ALS Network under which ALS ONE will become part of the ALS Network — combining Massachusetts-based research strength and Salesforce-linked corporate technology access with the ALS Network's national operational scale (California, Hawaii, and beyond). Chairman Mark Sullivan (Salesforce President/CRO of Regulated Industries) and Board Member Scott Gosnell will join the ALS Network Board of Directors, with Michael Braun as Advisory Trustee; the integration is expected to close in 2026 pending state and federal regulatory approvals.

Short descriptiontext

ALS ONE is a Massachusetts-based nonprofit that unites ALS researchers, clinicians, care providers, corporate leaders, and affected families through Research, Care, and Fundraising pillars to accelerate ALS treatment discovery and deliver resources to the ALS community.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWhitman, United States
HQ citystring
Whitman
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ALS research funding, nonprofit disease research, patient care services, neurological disease advocacy, charitable fundraising programs
Industry2 codes
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Other Individual and Family Services624190
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Nonprofit Disease Research and Patient Care
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Fundraising
TypeAffiliate Referral
Description

As a nonprofit organization, ALS ONE raises funds through donations, fundraising campaigns, and charitable contributions to support ALS research and care programs

alsone.org
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

ALS ONE is a Massachusetts-based nonprofit organization that funds ALS research and delivers care resources to individuals and families impacted by ALS. It operates through three program pillars—Research, Care, and Fundraising—bringing together leading ALS researchers, clinicians, care providers, corporate leaders, and families under a shared mission to accelerate treatment discovery, provide critical equipment and resources, and foster a connected community.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Expanded national impact through integration with ALS Network
+1 more record
Product overview1 text field

ALS ONE is a Massachusetts-based nonprofit organization that operates through three integrated pillars: Research (collaborative partnership of world-leading ALS researchers from institutions including ALS Therapy Development Institute, UMass Medical School, Massachusetts General Hospital, and Compassionate Care ALS), Care (providing critical equipment, resources, and support services for people living with ALS), and Fundraising (critical funding to advance united research and care initiatives). The organization unites researchers, clinicians, care providers, corporate leaders, and families impacted by ALS to accelerate treatment discovery and provide immediate practical support. ALS ONE is currently undergoing a strategic integration with the ALS Network (expected to complete in 2026) to expand national impact while maintaining its Massachusetts research partnerships.

Product and service3 records
1Research
CategoryCollaborative ALS Research
Description

A collaborative partnership of world-leading ALS researchers focused on finding a cure, leveraging expertise from leading Massachusetts institutions including ALS Therapy Development Institute, UMass Medical School, Massachusetts General Hospital (Healey Center for ALS), and Compassionate Care ALS.

2Care
CategoryALS Patient and Family Care Services
Description

Provision of critical care, essential equipment, technology, and support resources for individuals and families affected by ALS, delivered through the Compassionate Care ALS (CCALS) partnership.

3Fundraising
CategoryCharitable Fundraising
Description

Charitable fundraising initiatives to support ALS research and care programs, enabling collaboration among researchers, clinicians, caregivers, corporate leaders, and families through individual donations, corporate sponsorships, and foundation grants.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-11
Description

Strategic integration where ALS ONE becomes part of the ALS Network. The combination unites ALS ONE's Massachusetts-based research strength and corporate technology expertise with the ALS Network's national operational scale. Integration expected to complete in 2026 pending regulatory approvals. ALS ONE board members will join ALS Network Board of Directors.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Key research partner hosting the Healey Center for ALS. Dr. Merit Cudkowicz serves as Executive Director of Mass General Brigham Neuroscience Institute and Director of the Sean M. Healey & AMG Center for ALS. MGH researchers collaborate through ALS ONE's partnership model.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading ALS research institution included in ALS ONE's collaborative partnership of top ALS experts from Massachusetts institutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Key Massachusetts research institution partner in ALS ONE's collaborative research partnership focused on therapeutic development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Care organization partner providing technology, equipment and support services. Founder Ron Hoffman advocates for connecting scientific progress with practical support for ALS families.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Barcelona-based research institute that collaborated with ALS (ALS ONE) to develop PERLA®, a new class of organ preservation solution. PERLA® received CE marking for clinical use in organ transplantation.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Mark Sullivan, President and CRO of Regulated Industries at Salesforce, serves as Chairman of the ALS ONE Board of Directors. Salesforce network provides technology connections and corporate funding opportunities for ALS research.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Boston-based ALS drug discovery nonprofit that is both a research partner of ALS ONE and a comparable organization with translational science as its core mission.

TypeDirect peer
Description

The largest U.S. ALS-focused nonprofit, funding research, care services, and advocacy nationwide. Directly comparable mission, donation-driven model, and disease-specific focus.

TypeDirect peer
Description

ALS-focused nonprofit accelerating therapeutic development through partnerships and core facilities. Comparable translational research funding mission.

TypeBroad incumbent
Description

Larger neuromuscular disease nonprofit funding research and care across ALS, MD, and related conditions. Broader portfolio but overlaps on ALS research and patient services.

TypeDirect peer
Description

California-based ALS nonprofit (formerly ALS Golden West) that is absorbing ALS ONE through a 2026 strategic integration. Closest peer in mission, scope, and integration counterpart.

6Robert Packard Center for ALS Research
TypeDirect peer
Description

Johns Hopkins-based ALS research center funding collaborative science. Comparable academic-anchored ALS research funding model.

7Project ALS
TypeDirect peer
Description

Nonprofit funding collaborative ALS research at leading academic and industry labs. Comparable research-funding model and disease-specific mission.

TypeDirect peer
Description

Massachusetts-based ALS care nonprofit that is both a partner and a peer; provides direct equipment, education, and support to people living with ALS.

TypeDirect peer
Description

Chicago-based ALS-specific nonprofit funding research and providing patient services. Comparable disease-specific scope, regional anchor, and care-plus-research model.

TypeDirect peer
Description

ALS research consortium producing large-scale multi-omic data for ALS therapeutics. Comparable research-grantmaking focus on a single disease.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ALS ONE

Nonprofit Disease Research and Patient Carealsone.org

ALS ONE is a Massachusetts-based nonprofit that unites ALS researchers, clinicians, care providers, corporate leaders, and affected families through Research, Care, and Fundraising pillars to accelerate ALS treatment discovery and deliver resources to the ALS community.

What ALS ONE does

ALS ONE is a Massachusetts-based nonprofit organization founded around 2015 that unites world-leading ALS researchers, clinicians, care providers, corporate leaders, and families affected by ALS to accelerate treatment discovery and deliver practical care resources. It operates through three integrated pillars: Research (a collaborative partnership drawing on ALS Therapy Development Institute, UMass Medical School, Massachusetts General Hospital / Healey Center for ALS, and Compassionate Care ALS), Care (provision of equipment, resources, and support services to families living with ALS), and Fundraising (donation campaigns that underwrite both research and care programs).

Its core technology stack is non-software: the principal proprietary contribution disclosed is PERLA®, a new class of organ preservation solution (PPS) co-developed with Barcelona-based IDIBAPS that has received CE marking for clinical use in organ transplantation, signaling activity beyond pure ALS into adjacent translational research. The organization is community-led, headcount is 1–10, and revenue is sourced from donations and fundraising rather than commercial product sales; services to families are provided at no cost.

On February 11, 2026, ALS ONE announced a strategic integration with the ALS Network under which ALS ONE will become part of the ALS Network — combining Massachusetts-based research strength and Salesforce-linked corporate technology access with the ALS Network's national operational scale (California, Hawaii, and beyond). Chairman Mark Sullivan (Salesforce President/CRO of Regulated Industries) and Board Member Scott Gosnell will join the ALS Network Board of Directors, with Michael Braun as Advisory Trustee; the integration is expected to close in 2026 pending state and federal regulatory approvals.

ALS ONE firmographics

Firmographics
Name
ALS ONE
Legal name
ALS ONE
Website
https://alsone.org
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
ALS ONE is a Massachusetts-based nonprofit that unites ALS researchers, clinicians, care providers, corporate leaders, and affected families through Research, Care, and Fundraising pillars to accelerate ALS treatment discovery and deliver resources to the ALS community.
Ownership category
akta.pro rank

ALS ONE industry classification

Industry
Product category
Nonprofit Disease Research and Patient Care
NAICS
Voluntary Health Organizations (813212), Other Individual and Family Services (624190)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking

Keywords

  • ALS research funding
  • Nonprofit disease research
  • Patient care services
  • Neurological disease advocacy
  • Charitable fundraising programs

Where ALS ONE is headquartered

Location

Headquarters

HQ city
Whitman
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ALS ONE business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Donations and Fundraising: As a nonprofit organization, ALS ONE raises funds through donations, fundraising campaigns, and charitable contributions to support ALS research and care programs

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

ALS ONE product offering

Product offering

Core offering

ALS ONE is a Massachusetts-based nonprofit organization that funds ALS research and delivers care resources to individuals and families impacted by ALS. It operates through three program pillars—Research, Care, and Fundraising—bringing together leading ALS researchers, clinicians, care providers, corporate leaders, and families under a shared mission to accelerate treatment discovery, provide critical equipment and resources, and foster a connected community.

Product overview

ALS ONE is a Massachusetts-based nonprofit organization that operates through three integrated pillars: Research (collaborative partnership of world-leading ALS researchers from institutions including ALS Therapy Development Institute, UMass Medical School, Massachusetts General Hospital, and Compassionate Care ALS), Care (providing critical equipment, resources, and support services for people living with ALS), and Fundraising (critical funding to advance united research and care initiatives). The organization unites researchers, clinicians, care providers, corporate leaders, and families impacted by ALS to accelerate treatment discovery and provide immediate practical support. ALS ONE is currently undergoing a strategic integration with the ALS Network (expected to complete in 2026) to expand national impact while maintaining its Massachusetts research partnerships.

Differentiator

Problem solved

Functional benefit

Products and services

  • Research A collaborative partnership of world-leading ALS researchers focused on finding a cure, leveraging expertise from leading Massachusetts institutions including ALS Therapy Development Institute, UMass Medical School, Massachusetts General Hospital (Healey Center for ALS), and Compassionate Care ALS.
  • Care Provision of critical care, essential equipment, technology, and support resources for individuals and families affected by ALS, delivered through the Compassionate Care ALS (CCALS) partnership.
  • Fundraising Charitable fundraising initiatives to support ALS research and care programs, enabling collaboration among researchers, clinicians, caregivers, corporate leaders, and families through individual donations, corporate sponsorships, and foundation grants.

Quantifiable outcome

  • Expanded national impact through integration with ALS Network
  • +1 more outcomes

Companies that use ALS ONE

Customer profile

Segments2 records

Ideal customer profiles3 records

ALS ONE technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

ALS ONE partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • ALS NetworkcoreStrategic or Co-development Partner · 11 February 2026Strategic integration where ALS ONE becomes part of the ALS Network. The combination unites ALS ONE's Massachusetts-based research strength and corporate technology expertise with the ALS Network's national operational scale. Integration expected to complete in 2026 pending regulatory approvals. ALS ONE board members will join ALS Network Board of Directors.
  • Massachusetts General Hospital (MGH)coreStrategic or Co-development PartnerKey research partner hosting the Healey Center for ALS. Dr. Merit Cudkowicz serves as Executive Director of Mass General Brigham Neuroscience Institute and Director of the Sean M. Healey & AMG Center for ALS. MGH researchers collaborate through ALS ONE's partnership model.
  • ALS Therapy Development InstitutecoreStrategic or Co-development PartnerLeading ALS research institution included in ALS ONE's collaborative partnership of top ALS experts from Massachusetts institutions.
  • UMass Medical SchoolcoreStrategic or Co-development PartnerKey Massachusetts research institution partner in ALS ONE's collaborative research partnership focused on therapeutic development.
  • Compassionate Care ALS (CCALS)coreStrategic or Co-development PartnerCare organization partner providing technology, equipment and support services. Founder Ron Hoffman advocates for connecting scientific progress with practical support for ALS families.
  • IDIBAPS (Barcelona)minorStrategic or Co-development PartnerBarcelona-based research institute that collaborated with ALS (ALS ONE) to develop PERLA®, a new class of organ preservation solution. PERLA® received CE marking for clinical use in organ transplantation.
  • SalesforceminorGTM or Marketing PartnerMark Sullivan, President and CRO of Regulated Industries at Salesforce, serves as Chairman of the ALS ONE Board of Directors. Salesforce network provides technology connections and corporate funding opportunities for ALS research.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

ALS ONE competitors and assessment

Company assessment

Direct peers

  • ALS Therapy Development Institute: Boston-based ALS drug discovery nonprofit that is both a research partner of ALS ONE and a comparable organization with translational science as its core mission.
  • ALS Association: The largest U.S. ALS-focused nonprofit, funding research, care services, and advocacy nationwide. Directly comparable mission, donation-driven model, and disease-specific focus.
  • Target ALS: ALS-focused nonprofit accelerating therapeutic development through partnerships and core facilities. Comparable translational research funding mission.
  • ALS Network: California-based ALS nonprofit (formerly ALS Golden West) that is absorbing ALS ONE through a 2026 strategic integration. Closest peer in mission, scope, and integration counterpart.
  • Robert Packard Center for ALS Research: Johns Hopkins-based ALS research center funding collaborative science. Comparable academic-anchored ALS research funding model.
  • Project ALS: Nonprofit funding collaborative ALS research at leading academic and industry labs. Comparable research-funding model and disease-specific mission.
  • Compassionate Care ALS: Massachusetts-based ALS care nonprofit that is both a partner and a peer; provides direct equipment, education, and support to people living with ALS.
  • Les Turner ALS Foundation: Chicago-based ALS-specific nonprofit funding research and providing patient services. Comparable disease-specific scope, regional anchor, and care-plus-research model.
  • Answer ALS Foundation: ALS research consortium producing large-scale multi-omic data for ALS therapeutics. Comparable research-grantmaking focus on a single disease.

Broad incumbents

  • Muscular Dystrophy Association: Larger neuromuscular disease nonprofit funding research and care across ALS, MD, and related conditions. Broader portfolio but overlaps on ALS research and patient services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

ALS ONE social profiles

Digital presence

ALS ONE financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ALS ONE leadership team

Management profile

Number of profiles

Profiles4 records

ALS ONE funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ALS ONE M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ALS ONE

What does ALS ONE do?

ALS ONE is a Massachusetts-based nonprofit organization that funds ALS research and delivers care resources to individuals and families impacted by ALS. It operates through three program pillars—Research, Care, and Fundraising—bringing together leading ALS researchers, clinicians, care providers, corporate leaders, and families under a shared mission to accelerate treatment discovery, provide critical equipment and resources, and foster a connected community.

Is ALS ONE a public or private company?

ALS ONE is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was ALS ONE founded?

ALS ONE was founded in 2015. It employs 1 to 10 people.

Where is ALS ONE based?

ALS ONE is headquartered in Whitman, United States, in the North America region.

How does ALS ONE make money?

One revenue line is on record: donations and Fundraising.

Who are ALS ONE's main competitors?

Direct peers on record are ALS Therapy Development Institute, ALS Association, Target ALS, ALS Network, Robert Packard Center for ALS Research, Project ALS, Compassionate Care ALS, Les Turner ALS Foundation and Answer ALS Foundation. Muscular Dystrophy Association is listed as a broad incumbent.

Does ALS ONE have an API?

No public API is recorded for ALS ONE.

What industry is ALS ONE in?

ALS ONE's product category is Nonprofit Disease Research and Patient Care. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813212 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireALS ONE and the ALS Network Align to Scale ALS Research and Technology Impact NationwideALS ONE and the ALS Network announced a strategic integration in which ALS ONE will become part of the ALS Network, uniting Massachusetts research strength and corporate technology expertise to accelerate progress in ALS treatment and care. The integration aims to strengthen research funding capabilities, expand technology use to improve patient outcomes, and scale impact nationally while preserving ALS ONE's commitment to Massachusetts-based research partners. The merger is expected to be completed in 2026, pending necessary regulatory state and federal approvals.AlsonePress & News – ALS ONEALS ONE, a Massachusetts-based non-profit focused on ALS research and care, announced a strategic integration with the ALS Network, a California-based non-profit serving the ALS community nationwide. The integration aims to combine ALS ONE's local research strength and care partnerships with the ALS Network's national operational scale to accelerate research funding and expand technology-driven patient outcomes. The merger, expected to close in 2026 pending regulatory approvals, will place ALS ONE board members on the ALS Network's governing board while maintaining ALS ONE's commitment to Massachusetts-based institutional partners.AlsnetworkALS ONE and the ALS Network Align to Scale ALS Research and Technology Impact NationwideALS ONE and the ALS Network announced a strategic integration on February 11, 2026, combining two nonprofit organizations dedicated to ALS research and patient care into a single entity. The merger aims to strengthen research funding capabilities, expand technology-driven solutions for patient outcomes, and scale impact nationally while maintaining ALS ONE's commitment to Massachusetts-based research partners. The consolidation is expected to be completed in 2026 pending regulatory state and federal approvals.MorningstarALS ONE and the ALS Network Align to Scale ALS Research and Technology Impact NationwideALS ONE and the ALS Network announced a strategic integration, with ALS ONE becoming part of the ALS Network to accelerate ALS treatment research and expand care resources nationwide. The integration, expected to be completed in 2026 pending regulatory approvals, will combine ALS ONE's Massachusetts-based research strength with the ALS Network's broader ecosystem to strengthen research funding and leverage technology for improved patient outcomes. The consolidation will preserve ALS ONE's commitment to Massachusetts-based research partners while expanding collaboration and funding opportunities nationally.PR NewswireMDA And ALS ONE Form New Partnership To Accelerate ALS Biomarker ResearchMDA announced a $750,000 human clinical trial grant to Massachusetts General Hospital, catalyzed by the ALS ONE partnership, to explore PET imaging of inflammation as a biomarker for ALS diagnosis and clinical trials. The research, led by Dr. Nazem Atassi at MGH's Neurological Clinical Research Institute, could reduce future ALS trial duration from 12 to 3 months and required patient enrollment from 400 to 30 patients. This biomarker tool would be made available to any researcher or pharmaceutical company to accelerate ALS drug development.PR NewswireThe ALS ONE Massachusetts ALS Partnership (MAP) Will Accelerate Treatment and Care in ALSThe ALS Association announced $2 million in funding to support the ALS ONE-Massachusetts ALS Partnership (MAP), a collaboration launched earlier in 2016 between Massachusetts General Hospital, ALS Therapy Development Institute, University of Massachusetts Medical School, and Compassionate Care ALS. The funding is part of a total $6 million commitment, with additional contributions of $2 million each from ALS Funding a Cure and ALS ONE itself, dedicated to accelerating ALS treatment development and care. The partnership, founded by the late Kevin Gosnell who passed away in August 2016, aims to establish a regional clinical trials network, develop preclinical pipelines, and move therapeutic candidates from lab to patient trials while improving care access for ALS patients.